TSS
APGN

Two Sigma Securities’s Apexigen, Inc. Common Stock APGN Stock Holding History

Two Sigma Securities’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,233
Closed -$6.12K – 3649
2023
Q2 		$6.12K Sell
14,233
-13,889
-49% -$6.57K ﹤0.01% 2654
2023
Q1 		$13.7K Buy
+28,122
New +$33.8K ﹤0.01% 2411

Two Sigma Securities's APGN Position: Q3 2023 in Review

Two Sigma Securities sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 14,233 shares — an estimated $6.12K sold.

Two Sigma Securities first reported a position in APGN in Q1 2023 and held it in 2 quarters. The position peaked at $13.7K in Q1 2023. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

  • Two Sigma Securities reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Securities sold 14,233 Apexigen, Inc. Common Stock shares in Q3 2023, an estimated $6.12K.
  • Two Sigma Securities first reported a position in Apexigen, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Two Sigma Securities's Apexigen, Inc. Common Stock position peaked at $13.7K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.